Related Experiment Video
Updated: May 12, 2026

09:08
From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Total synthesis of (+)-pleuromutilin
Neal J Fazakerley1, Matthew D Helm, David J Procter
1School of Chemistry, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|April 17, 2013
Summary
Researchers achieved the first enantiospecific total synthesis of the antibacterial natural product (+)-pleuromutilin. This breakthrough utilized a novel cyclization cascade and efficient conversion methods for enhanced drug development.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Natural Product Synthesis
Background:
- Pleuromutilin is a natural product with significant antibacterial activity.
- Existing synthetic routes to pleuromutilin derivatives are often lengthy or lack stereochemical control.
- The development of an enantiospecific total synthesis is crucial for accessing novel analogs and understanding structure-activity relationships.
Purpose of the Study:
- To achieve the first enantiospecific total synthesis of the natural product (+)-pleuromutilin.
- To develop a novel synthetic strategy enabling efficient and stereoselective construction of the pleuromutilin core.
- To provide a scalable route for the synthesis of (+)-pleuromutilin and its derivatives for further biological evaluation.
Main Methods:
- Synthesis of a non-racemic cyclisation substrate derived from (+)-trans-dihydrocarvone.
- Implementation of a highly selective Samarium(II) iodide (SmI2)-mediated cyclisation cascade.
- Utilisation of an electron transfer reduction for a sterically hindered ester and efficient conversion of (+)-mutilin.
Main Results:
- Successful enantiospecific total synthesis of (+)-pleuromutilin.
- Demonstration of a highly selective SmI2-mediated cyclisation cascade for constructing the core structure.
- Efficient conversion of (+)-mutilin to the target molecule, showcasing the utility of the developed methodology.
Conclusions:
- The developed synthetic route represents a significant advancement in the total synthesis of pleuromutilin.
- This enantiospecific approach provides access to enantiomerically pure (+)-pleuromutilin, facilitating further medicinal chemistry efforts.
- The methodology is amenable to the synthesis of diverse pleuromutilin analogs with potential antibacterial applications.
